Jerzy Gumulka

CNSP

DIRECTOR · CNS PHARMACEUTICALS, INC. · CIK 0001793252

FILING MIX · LIFETIME100%/0%

BUYS

SELLS

TOTAL VALUE

$19.6K

COMPANIES

ACTIVE SINCE

Jun 2020

HOLDINGS NOW

1,517

AVG SELL PX

—

Trades · vs SPY

Loading price series…

Performance · forward returns vs SPY

2 backtested trades · 8 horizonsHow are these numbers computed? →

Forward-return performance of every backtestable P/S trade by Jerzy Gumulka, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.

HORIZON	TRADES	WIN RATE	INSIDER RETURN	SPY RETURN	MEAN EXCESS	MEDIAN EXCESS	T-STAT
7d	2	+50.00%	+131.55%	-0.65%	+132.20%	+132.20%	—
14d	2	+100.00%	+77.70%	-0.37%	+78.07%	+78.07%	—
30d	2	+50.00%	+51.03%	+0.94%	+50.09%	+50.09%	—
60d	2	+100.00%	+103.84%	+5.73%	+98.11%	+98.11%	—
90d	2	+100.00%	+121.50%	+8.91%	+112.59%	+112.59%	—
180d	2	+50.00%	+15.84%	+5.84%	+10.00%	+10.00%	—
1y	2	+0.00%	-78.95%	+25.49%	-104.45%	-104.45%	—
2y	2	+0.00%	-99.96%	+34.10%	-134.06%	-134.06%	—

How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.

Holdings over time

CNSP · 1,517 shares · as of Nov 17, 2025

Trading cadence · quarterly flow

BUY ● SELL ●

2020

2021

2022

2023

2024

2025

FLOW · 12 buys / 0 sellsCOVERAGE · 23 quarters

Form 4 filings · all activity

COMPANY	TYPE	SHARES	PRICE	VALUE	HELD AFTER	TRADE DATE	FILED	DETAILS
CNSP CNS PHARMACEUTICALS, INC.	PURCHASEGRANT Stock grant	1,517	—	—	1,517	Nov 17, 2025	Nov 19, 2025 ↗	View →
CNSP CNS PHARMACEUTICALS, INC.	PURCHASEGRANT Stock grant	17,500	—	—	147,594	Apr 8, 2024	Apr 10, 2024 ↗	View →
CNSP CNS PHARMACEUTICALS, INC.	PURCHASEGRANT Stock grant	17,500	—	—	129,594	Apr 8, 2024	Apr 10, 2024 ↗	View →
CNSP CNS PHARMACEUTICALS, INC.	PURCHASEGRANT Stock grant	33,333	—	—	78,761	Feb 1, 2024	Feb 5, 2024 ↗	View →
CNSP CNS PHARMACEUTICALS, INC.	PURCHASE	33,333	$0.30	$10.0K	43,006	Feb 1, 2024	Feb 5, 2024 ↗	View →
CNSP CNS PHARMACEUTICALS, INC.	PURCHASEGRANT Stock grant	33,333	—	—	112,094	Feb 1, 2024	Feb 5, 2024 ↗	View →
CNSP CNS PHARMACEUTICALS, INC.	PURCHASEGRANT Stock grant	68,961	—	—	74,914	Sep 21, 2023	Sep 25, 2023 ↗	View →
CNSP CNS PHARMACEUTICALS, INC.	PURCHASEGRANT Stock grant	39,475	—	—	45,428	Sep 21, 2023	Oct 12, 2023 ↗	View →
CNSP CNS PHARMACEUTICALS, INC.	PURCHASE	2,500	$1.70	$4.3K	9,673	Apr 19, 2023	Apr 21, 2023 ↗	View →
CNSP CNS PHARMACEUTICALS, INC.	PURCHASE	7,173	$0.74	$5.3K	7,173	Apr 10, 2023	Apr 17, 2023 ↗	View →
CNSP CNS PHARMACEUTICALS, INC.	PURCHASEGRANT Stock grant	32,000	—	—	178,559	Jul 15, 2021	Jul 16, 2021 ↗	View →
CNSP CNS PHARMACEUTICALS, INC.	PURCHASEGRANT Stock grant	46,559	—	—	146,559	Jun 12, 2020	Jun 16, 2020 ↗	View →

Other insiders · CNSP

Loading peer insiders…

About this filer

CIK 0001793252

ROLE

Director

PRIMARY

CNSP

COMPANIES

ACTIVE SINCE

Jun 2020

MARKETPEEL · /INSIDER/0001793252DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE

Jerzy Gumulka

The morning brief, before the bell.